Drug recalls

Bleomycin for Injection, USP, 15 units per vial, 1 single dose glass fliptop vial, Rx Only, Distributed by: Hospira, Inc., Lake Forest, IL…

PFIZER · Presence of particulate matter: glass

Class IOngoingD-0261-2024
Status
Ongoing
City
New York
State
NY
Country
United States
Classification
Class I
Product type
Drugs
Event ID
93693
Recalling firm
PFIZER
Address 1
66 Hudson St
Address 2
N/A
Postal code
10013
Voluntary mandated
Voluntary: Firm initiated
Initial firm notification
Press Release
Distribution pattern
Nationwide in the USA, Netherlands and Libya
Recall number
D-0261-2024
Product quantity
3,546 vials
Reason for recall
Presence of particulate matter: glass
Recall initiation date
20231221
Center classification date
20240125
Report date
20240131
Code info
Lot #: BL12206A, Exp date 06/30/2024
Product description

Bleomycin for Injection, USP, 15 units per vial, 1 single dose glass fliptop vial, Rx Only, Distributed by: Hospira, Inc., Lake Forest, IL 68045, NDC 61703-332-18

Harmonized identifiers (openFDA)
Application number
ANDA065031
Brand name
BLEOMYCIN
Generic name
BLEOMYCIN
Manufacturer name
Hospira, Inc.
Product NDC
61703-323, 61703-332
Product type
HUMAN PRESCRIPTION DRUG
Route
INTRAMUSCULAR, INTRAPLEURAL, INTRAVENOUS, SUBCUTANEOUS
Substance name
BLEOMYCIN SULFATE
RxCUI
1726673, 1726676
SPL ID
6615dbd2-3bb4-40b5-8599-aa46bc0bc488
SPL set ID
905e0984-2ce3-481c-b1a0-0ef0a616479a
Package NDC
61703-323-22, 61703-332-18
Is original packager
true
UNII
7DP3NTV15T
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.